Sandra S Snapp

Array ( [id] => 457067 [patent_doc_number] => 07244840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Admixture, extrudable hydraulic composition and method for the selection of admixture' [patent_app_type] => utility [patent_app_number] => 11/340576 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2656 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244840.pdf [firstpage_image] =>[orig_patent_app_number] => 11340576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801371 [patent_doc_number] => 20060035862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Tolerance of 4-(4-(2-pyrrolycarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration' [patent_app_type] => utility [patent_app_number] => 11/257666 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2747 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035862.pdf [firstpage_image] =>[orig_patent_app_number] => 11257666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7226226 [patent_doc_number] => 20050269265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Carbohydrate purification using ultrafiltration, reverse osmosis and nanofiltration' [patent_app_type] => utility [patent_app_number] => 11/198839 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14351 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20050269265.pdf [firstpage_image] =>[orig_patent_app_number] => 11198839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926470 [patent_doc_number] => 20050239726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Novel nucleosides and related processes, pharmaceutical compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/171181 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19014 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239726.pdf [firstpage_image] =>[orig_patent_app_number] => 11171181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895412 [patent_doc_number] => 20060003951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Anti-viral 7-deaza L-nucleosides' [patent_app_type] => utility [patent_app_number] => 11/150591 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4347 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003951.pdf [firstpage_image] =>[orig_patent_app_number] => 11150591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020067 [patent_doc_number] => 20050222086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Alprazolam inclusion complexes and pharmaceutical composition thereof' [patent_app_type] => utility [patent_app_number] => 11/144965 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5061 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222086.pdf [firstpage_image] =>[orig_patent_app_number] => 11144965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952849 [patent_doc_number] => 20050227944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Method of treating leishmaniasis using methyl-beta-cyclodextrin' [patent_app_type] => utility [patent_app_number] => 11/141573 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4136 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227944.pdf [firstpage_image] =>[orig_patent_app_number] => 11141573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680057 [patent_doc_number] => 07084132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Artemisinins with improved stability and bioavailability for therapeutic drug development and application' [patent_app_type] => utility [patent_app_number] => 11/113546 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 40 [patent_no_of_words] => 6188 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084132.pdf [firstpage_image] =>[orig_patent_app_number] => 11113546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769786 [patent_doc_number] => 20050266148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Photocleavable protecting groups and methods for their use' [patent_app_type] => utility [patent_app_number] => 11/105571 [patent_app_country] => US [patent_app_date] => 2005-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9198 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266148.pdf [firstpage_image] =>[orig_patent_app_number] => 11105571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075272 [patent_doc_number] => 20050148540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Di(uridine 5\'-)tetraphosphate and salts thereof' [patent_app_type] => utility [patent_app_number] => 11/055170 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10452 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148540.pdf [firstpage_image] =>[orig_patent_app_number] => 11055170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997372 [patent_doc_number] => 20050137150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Forms of 5-azacytidine' [patent_app_type] => utility [patent_app_number] => 11/052615 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6624 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137150.pdf [firstpage_image] =>[orig_patent_app_number] => 11052615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 655266 [patent_doc_number] => 07109324 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-19 [patent_title] => 'Process for chemically bonding an odor-encapsulating agent to textiles and textiles formed by the process' [patent_app_type] => utility [patent_app_number] => 11/052332 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7666 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109324.pdf [firstpage_image] =>[orig_patent_app_number] => 11052332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098510 [patent_doc_number] => 20050130969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => '4\'-Thio-L-xyloy furanosyl nucleosides, precursors thereof, preparation and use thereof' [patent_app_type] => utility [patent_app_number] => 11/045085 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5108 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130969.pdf [firstpage_image] =>[orig_patent_app_number] => 11045085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630449 [patent_doc_number] => 07132409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Adenosine derivatives and use thereof' [patent_app_type] => utility [patent_app_number] => 11/032020 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4779 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132409.pdf [firstpage_image] =>[orig_patent_app_number] => 11032020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982815 [patent_doc_number] => 20050152885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Colorectal neoplasia prophylaxis' [patent_app_type] => utility [patent_app_number] => 11/023825 [patent_app_country] => US [patent_app_date] => 2004-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3018 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152885.pdf [firstpage_image] =>[orig_patent_app_number] => 11023825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543093 [patent_doc_number] => 07169767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Ophthalmic compositions containing galactomannan polymers and borate' [patent_app_type] => utility [patent_app_number] => 10/997643 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4160 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169767.pdf [firstpage_image] =>[orig_patent_app_number] => 10997643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983838 [patent_doc_number] => 20050153908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Use of ribofuranose derivatives against inflammatory bowel diseases' [patent_app_type] => utility [patent_app_number] => 10/995607 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7955 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153908.pdf [firstpage_image] =>[orig_patent_app_number] => 10995607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983837 [patent_doc_number] => 20050153907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Use of ribofuranose derivatives against inflammatory bowel diseases' [patent_app_type] => utility [patent_app_number] => 10/995595 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7953 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153907.pdf [firstpage_image] =>[orig_patent_app_number] => 10995595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 620167 [patent_doc_number] => 07141582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-28 [patent_title] => 'Method for enhancing mutant enzyme activities in Gaucher disease' [patent_app_type] => utility [patent_app_number] => 10/989258 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 11833 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141582.pdf [firstpage_image] =>[orig_patent_app_number] => 10989258 [rel_patent_id] =>[rel_patent_doc_number] =>)